Mobile Menu - OpenMobile Menu - Closed

Energy and Commerce Cures

News and Commentary | White Papers and Public Feedback | Hearings, Roundtables, and Forums

Follow the #Path2Cures: The 21st Century Cures Act was approved by the House on July 10, 2015. Next Stop: U.S. Senate

Key Documents

Must Read

Must Watch


Chairman Upton and Rep. DeGette discuss their vision for the 21st Centurcy Cures initiative in April 2014

Physician and Pulitzer Prize-winning author Dr. Siddhartha Mukherjee discusses the 21st Century Cures Act



Congress is working together on a nonpartisan issue that will have a profound effect on the lives of all Americans. H.R. 6, the 21st Century Cures Act, will bring our health care innovation infrastructure into the 21st Century, delivering hope for patients and loved ones and providing necessary resources to researchers to continue their efforts to uncover the next generation of cures and treatments. 

In the 21st century, health care innovation is happening at lightning speed. From the mapping of the human genome to the rise of personalized medicines that are linked to advances in molecular medicine, we have seen constant breakthroughs that are changing the face of disease treatment, management, and cures. Health research is moving quickly, but the federal drug and device approval apparatus is in many ways the relic of another era. We have dedicated scientists and bold leaders at agencies like the NIH and the FDA, but when our laws don’t keep pace with innovation, we all lose.

If we want to save more lives and keep this country the leader in medical innovation, we have to make sure there’s not a major gap between the science of cures and the way we regulate these therapies.

That is why, for the first time ever, we in Congress have taken a comprehensive look at what steps we can take to accelerate the pace of cures in America. We have looked at the full arc of this process – from the discovery of clues in basic science, to streamlining the drug and device development process, to unleashing the power of digital medicine and social media at the treatment delivery phase. We took our time, listening to the experts who know best. We’ve been working with patients, patient advocates, researchers, and innovators in the health care system to learn more about how to close the gaps between advances in scientific knowledge about cures and the regulatory policies created to save more lives. 

For over a year now, members have taken this important conversation back home to districts all across the country, and now it's time to take those ideas and bring them to life.

On May 21, 2015, the committee voted 51-0 to advance the 21st Century Cures Act, a bill to help modernize and personalize health care, encourage greater innovation, support research, and streamline the system. As this nonpartisan legislation makes its way to the president’s desk we encourage you to stay up to date with the effort here and on social media using #Cures2015. 

Connect with Us

The committee is seeking input on this bold new initiative from a wide variety of interested stakeholders.

Engage on social media by liking us on Facebook, Following us on Twitter, and using the hashtags #Path2Cures and #Cures2015.

Email the committee using the email address

21st Century Cures is a truly collaborative effort. Please be advised that submissions sent to will be made publicly available on as part of the effort to encourage continued discussion about opportunities and ideas to accelerate the pace of cures. We thank you for participating.

More on Energy and Commerce Cures

Jul 17, 2017 Blog

WASHINGTON, DC – FDA Commissioner Scott Gottlieb, M.D. posted a blog on Monday detailing the agency’s new hiring program to fill hundreds of jobs, in part under the landmark 21st Century Cures Act.

Jul 10, 2017 Blog

WASHINGTON, DC – FDA Commissioner Scott Gottlieb, M.D. posted a blog on Friday detailing the agency’s plans to implement the landmark 21st Century Cures Act, as well as updates on individual initiatives within the bill.

Feb 14, 2017 Press Release

WASHINGTON, DC –  Ahead of today’s #SubDCCP hearing, Chairman Bob Latta (R-OH) previews what audiences can expect the subcommittee to explore in the 115th Congress. First up, the exciting reality of once-futuristic technology: self-driving cars. 

 Watch the video below and be sure to tune into today’s hearing, “Self-Driving Cars: Road to Deployment” at 10:15 a.m. 

Jan 19, 2017 Press Release

WASHINGTON, DC – House Energy and Commerce Committee Chairman Greg Walden (R-OR) and Ranking Member Frank Pallone, Jr. (D-NJ) today welcomed the FDA’s establishment of an Oncology Center of Excellence. The announcement, part of Vice President Biden’s cancer moonshot initiative, is the culmination of the FDA’s June 2016 announcement to create the first-of-its-kind center.

Dec 19, 2016 In the News

WASHINGTON, DC – It’s not every day a superhero comes to town. But that’s exactly what happened on Friday.

Meet Kaheem – or Super Kaheem, as he’s known around town – a five-year-old boy from Owings Mills, Maryland. Kaheem has been battling leukemia, and is part of the Make-A-Wish program.

Dec 15, 2016 Blog

In reflecting on the three-year journey of #CuresNow becoming law, there was one young advocate who was there every step of the way – our friend Max. The tiniest of advocates first joined the #Path2Cures in the late spring of 2015 at the tender age of six. Max has been a critical voice and played an important role in helping us get this game-changing innovation package across the finish line.

Dec 14, 2016 In the News

With the 21st Century Cures Act now law, two key officials from the National Institutes of Health (NIH) took to the New England Journal of Medicine to outline the game-changing legislation from their purview.

Dec 14, 2016 Press Release

WASHINGTON, DC – Four years after the tragic shooting at Sandy Hook Elementary School in Newtown, Connecticut, meaningful mental health reforms are now law. President Obama signed the 21st Century Cures Act into law yesterday, which included mental health reforms spearheaded by Oversight and Investigations Subcommittee Chairman Tim Murphy (R-PA).